Cannabis Dispensary and Brands in San Francisco, California to Donate Proceeds Next Week to Support Ukraine
A dispensary in San Francisco, CA, joined with nearly two dozen cannabis brands, will donate proceeds starting on March 6 to support humanitarian aid in Ukraine.
Starting Sunday, March 6, 2022, MediThrive, joined with nearly two dozen other cannabis brands, will donate proceeds to Sunflower of Peace, an organization providing medical and humanitarian aid to paramedics and doctors to help those affected by the violence in Ukraine. On March 6, MediThrive, operated by Ukrainian Americans, plans to donate 100% of its in-person and online sales, then 10% of sales until March 13.
MediThrive CEO Misha Breyburg and his colleagues immigrated from Odessa, Ukraine in the 1970s. “I know we are all hurting from this crisis, but I never expected such overwhelming support to help a community and country that I hold close to my heart,” Breyburg said, recounting his experience speaking with participating cannabis brands.
To learn more about Sunflower of Peace, visit: https://www.sunflowerofpeace.com/
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
